TY - JOUR
T1 - Spinocerebellar ataxias in Southern Brazil
T2 - Genotypic and phenotypic evaluation of 213 families
AU - Nascimento, Fábio A.
AU - Rodrigues, Vinícius O.R.
AU - Pelloso, Fernando C.
AU - Camargo, Carlos Henrique Ferreira
AU - Moro, Adriana
AU - Raskin, Salmo
AU - Ashizawa, Tetsuo
AU - Teive, Hélio Afonso Ghizoni
N1 - Publisher Copyright:
© 2019 Elsevier B.V.
PY - 2019/9
Y1 - 2019/9
N2 - Objectives: To describe and correlate the genotype and phenotype of patients diagnosed with SCAs in southern of Brazil. Patients and methods: Data were collected from the records of our ataxia outpatient clinic. We included 460 patients from 213 families, who were divided into four groups: SCA3, SCA10, Other SCAs and Undetermined. Results: The most frequent type was SCA3 (45.7%), followed by SCA10 (18.3%), SCA2 (6.5%), SCA1 (4.3%), SCA7 (1.8%), and SCA6 (0.65%). The Undetermined group represented 22.8% of all patients. We observed a high frequency of SCA10 when compared to data from other studies, which can be explained by a founder effect in our region. Statistically significant differences were found for several symptoms when comparing SCA groups, especially lid retraction (p < 0.001), ophthalmoplegia (p < 0.001), visual loss (p < 0.001) and slow saccades (p < 0.001) which may help clinically differentiate SCAs and allow neurologists to request the right confirmatory genetic test and define prognosis. Also, the prevalence of epilepsy in SCA10 patients was lower than usual (4.8%), suggesting a genetic variation of the disease. Conclusion: Although SCA3 remains the most common, we observed a high frequency of SCA10 in our region. In addition, some symptoms and signs might help differentiate the SCAs.
AB - Objectives: To describe and correlate the genotype and phenotype of patients diagnosed with SCAs in southern of Brazil. Patients and methods: Data were collected from the records of our ataxia outpatient clinic. We included 460 patients from 213 families, who were divided into four groups: SCA3, SCA10, Other SCAs and Undetermined. Results: The most frequent type was SCA3 (45.7%), followed by SCA10 (18.3%), SCA2 (6.5%), SCA1 (4.3%), SCA7 (1.8%), and SCA6 (0.65%). The Undetermined group represented 22.8% of all patients. We observed a high frequency of SCA10 when compared to data from other studies, which can be explained by a founder effect in our region. Statistically significant differences were found for several symptoms when comparing SCA groups, especially lid retraction (p < 0.001), ophthalmoplegia (p < 0.001), visual loss (p < 0.001) and slow saccades (p < 0.001) which may help clinically differentiate SCAs and allow neurologists to request the right confirmatory genetic test and define prognosis. Also, the prevalence of epilepsy in SCA10 patients was lower than usual (4.8%), suggesting a genetic variation of the disease. Conclusion: Although SCA3 remains the most common, we observed a high frequency of SCA10 in our region. In addition, some symptoms and signs might help differentiate the SCAs.
KW - Autosomal dominant cerebellar ataxia
KW - Machado-Joseph disease
KW - SCA10
KW - SCA3
KW - Spinocerebellar ataxias
UR - http://www.scopus.com/inward/record.url?scp=85068857039&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85068857039&partnerID=8YFLogxK
U2 - 10.1016/j.clineuro.2019.105427
DO - 10.1016/j.clineuro.2019.105427
M3 - Article
C2 - 31323545
AN - SCOPUS:85068857039
SN - 0303-8467
VL - 184
JO - Clinical Neurology and Neurosurgery
JF - Clinical Neurology and Neurosurgery
M1 - 105427
ER -